Published in Oncogene on January 30, 2006
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer (2008) 2.13
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res (2007) 1.93
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res (2009) 1.70
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer (2008) 1.63
Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia (2010) 1.58
Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies. Proc Natl Acad Sci U S A (2010) 1.49
Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog (2011) 1.44
Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer (2009) 1.43
Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet (2006) 1.40
Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J Cell Mol Med (2008) 1.33
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Breast Cancer Res (2008) 1.29
Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One (2010) 1.26
Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol (2008) 1.25
Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res (2010) 1.24
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer. BMC Cancer (2008) 1.23
Epigenomics and breast cancer. Pharmacogenomics (2008) 1.23
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res (2008) 1.21
Early detection of ovarian cancer. Biomark Med (2008) 1.20
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer (2009) 1.19
Hedgehog signalling in breast cancer. Carcinogenesis (2009) 1.18
Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival. Clin Cancer Res (2011) 1.15
The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS One (2009) 1.12
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol Cancer (2008) 1.11
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set. PLoS One (2015) 1.06
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer. Breast Cancer Res (2009) 1.05
Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Sci Rep (2015) 1.04
Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors. Carcinogenesis (2013) 1.01
Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells. J Cell Mol Med (2013) 1.00
Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikis. Cancer Cell Int (2009) 0.99
Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Cancer Ther (2012) 0.97
Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy. Breast Cancer Res (2009) 0.97
Genome-wide epigenetic modifications in cancer. Prog Drug Res (2011) 0.93
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. Br J Cancer (2010) 0.93
Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology (2007) 0.91
Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics (2010) 0.90
Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer. Br J Cancer (2011) 0.90
Aberrant promoter CpG methylation and its translational applications in breast cancer. Chin J Cancer (2011) 0.90
The complex roles of Wnt antagonists in RCC. Nat Rev Urol (2011) 0.89
Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer (2009) 0.89
Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer. Br J Cancer (2009) 0.88
Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma. PLoS One (2011) 0.87
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Gynecol Oncol (2012) 0.86
Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk. Int J Clin Exp Pathol (2013) 0.85
Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma. Dig Dis Sci (2009) 0.84
Secreted Frizzled-related protein 1 (sFRP1) regulates spermatid adhesion in the testis via dephosphorylation of focal adhesion kinase and the nectin-3 adhesion protein complex. FASEB J (2012) 0.84
sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration. Arch Biochem Biophys (2011) 0.84
Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis. Breast Cancer Res (2012) 0.84
[Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation]. Pathologe (2008) 0.84
Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development. Breast Cancer Res (2010) 0.84
Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma. Dig Dis Sci (2011) 0.84
DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression. Breast Cancer Res (2014) 0.84
Dickkopf1 regulates fate decision and drives breast cancer stem cells to differentiation: an experimentally supported mathematical model. PLoS One (2011) 0.83
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation. J Mol Diagn (2010) 0.83
[Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer]. Pathologe (2008) 0.83
Global and gene-specific promoter methylation analysis in primary hyperparathyroidism. Epigenetics (2013) 0.81
Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway. Oncogene (2016) 0.81
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis. BMC Cancer (2012) 0.81
Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression. PLoS One (2014) 0.81
BDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression? PLoS One (2014) 0.80
Intramucosal distribution of WNT signaling components in human esophagus. J Clin Gastroenterol (2009) 0.80
Functional analyses and prognostic significance of SFRP1 expression in bladder cancer. J Cancer Res Clin Oncol (2015) 0.79
Breast cancer-initiating cells: insights into novel treatment strategies. Cancers (Basel) (2011) 0.79
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Int J Gynecol Cancer (2016) 0.79
Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome. Epigenetics (2015) 0.79
Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma. Mol Med (2014) 0.79
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling. Mol Cancer (2014) 0.79
Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype. Epigenetics (2014) 0.78
Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer. Cancers (Basel) (2016) 0.78
Differential expression of centrosome regulators in Her2+ breast cancer cells versus non-tumorigenic MCF10A cells. Cell Div (2014) 0.78
Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review. Bosn J Basic Med Sci (2014) 0.77
Targets of Wnt/ß-catenin transcription in penile carcinoma. PLoS One (2015) 0.77
DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes. PLoS One (2015) 0.77
Activation of the Wnt/β-catenin signaling cascade after traumatic nerve injury. Neuroscience (2015) 0.77
In silico Identification of SFRP1 as a Hypermethylated Gene in Colorectal Cancers. Genomics Inform (2014) 0.76
Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis. Onco Targets Ther (2015) 0.76
ITIH5 mediates epigenetic reprogramming of breast cancer cells. Mol Cancer (2017) 0.75
Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4. Front Pharmacol (2017) 0.75
Exploring the intrinsic differences among breast tumor subtypes defined using immunohistochemistry markers based on the decision tree. Sci Rep (2016) 0.75
Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial. PLoS One (2017) 0.75
Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells. Proc Natl Acad Sci U S A (2016) 0.75
A pan-cancer analysis of secreted Frizzled-related proteins: re-examining their proposed tumour suppressive function. Sci Rep (2017) 0.75
MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland. Oncogenesis (2016) 0.75
Genome-wide identification of key modulators of gene-gene interaction networks in breast cancer. BMC Genomics (2017) 0.75
Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma. J Appl Genet (2017) 0.75
The sequence of the human genome. Science (2001) 101.55
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol (1985) 4.82
Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A (1999) 3.13
Trends in smoking behaviour between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health (2005) 3.01
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer (2008) 2.67
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol (2004) 2.45
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A (1987) 2.40
Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol (1996) 2.26
European and US publications in the 50 highest ranking pathology journals from 2000 to 2006. J Clin Pathol (2007) 2.20
Real-time elastography--an advanced method of ultrasound: First results in 108 patients with breast lesions. Ultrasound Obstet Gynecol (2006) 2.12
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene (2007) 2.08
Mortality and life expectancy after hip fractures. Acta Orthop Scand (1980) 1.97
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 5. General discussion and conclusions. Cleft Palate Craniofac J (1992) 1.92
Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn Reson Med (1998) 1.92
Osseointegrated oral implants. A Swedish multicenter study of 8139 consecutively inserted Nobelpharma implants. J Periodontol (1988) 1.83
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80
Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med (Berl) (1997) 1.77
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene (2007) 1.63
Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant (2007) 1.63
Light-induced enzyme synthesis in cell suspension cultures of Petroselinum hortense. Demonstration in a heterologous cell-free system of rapid changes in the rate of phenylalanine ammonia-lyase synthesis. Eur J Biochem (1976) 1.62
Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer (2000) 1.60
Cleft lip and palate in Denmark, 1976-1981: epidemiology, variability, and early somatic development. Cleft Palate J (1988) 1.60
Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol (2010) 1.59
The diversity of connexin genes encoding gap junctional proteins. Eur J Cell Biol (1991) 1.57
Intervertebral disk appearance correlated with stiffness of lumbar spinal motion segments. AJNR Am J Neuroradiol (1999) 1.56
Mouse connexin37: cloning and functional expression of a gap junction gene highly expressed in lung. J Cell Biol (1991) 1.53
Molecular cloning and functional expression of mouse connexin40, a second gap junction gene preferentially expressed in lung. J Cell Biol (1992) 1.49
Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene (1992) 1.46
Cranial base in newborns with complete cleft lip and palate: radiographic study. Cleft Palate Craniofac J (1995) 1.45
Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc (1999) 1.45
Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first-line treatment option. BJOG (2013) 1.42
Clonal culture of fetal cells from maternal blood. Lancet (2000) 1.41
Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol (1999) 1.41
X-ray crystallographic analysis of the hydration of A- and B-form DNA at atomic resolution. Biopolymers (1998) 1.40
The application of the ethyl iodide method to the determination of the circulation rate in women. J Physiol (1926) 1.40
Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. J Magn Reson Imaging (2001) 1.38
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. Nucleic Acids Res (1999) 1.37
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37
Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology (2001) 1.36
Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. Circ Res (1997) 1.35
Serial cine-magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats. J Magn Reson Imaging (2001) 1.35
Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer (1992) 1.33
Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virology (1991) 1.32
Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer (2001) 1.31
Presence of human papillomavirus in genital tumors. J Invest Dermatol (1984) 1.29
Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation (2000) 1.26
Expression of AGR2 in non small cell lung cancer. Histol Histopathol (2007) 1.26
Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer (2003) 1.25
Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol (1992) 1.25
MR navigator-echo monitoring of temporal changes in diaphragm position: implications for MR coronary angiography. J Magn Reson Imaging (1997) 1.24
The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem Sci (2001) 1.22
Isolation and characterization of the regulatory HEX2 gene necessary for glucose repression in yeast. Mol Gen Genet (1987) 1.22
Toxoplasma gondii infections in cats from Paraná, Brazil: seroprevalence, tissue distribution, and biologic and genetic characterization of isolates. J Parasitol (2004) 1.22
Targeted disruption of Pax1 defines its null phenotype and proves haploinsufficiency. Proc Natl Acad Sci U S A (1998) 1.22
Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus. J Biol Chem (1995) 1.20
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol (2006) 1.17
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene (2007) 1.17
Aluminium accumulation and immunosuppressive effect in recipients of kidney transplants. BMJ (1988) 1.17
Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system. Dev Dyn (1995) 1.17
Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. Proc Natl Acad Sci U S A (1997) 1.17
ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies. Prostate Cancer Prostatic Dis (2012) 1.16
Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol (1996) 1.15
Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro. Oncogene (2011) 1.15
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene (2006) 1.15
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program. Bone Marrow Transplant (2010) 1.14
Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer (1996) 1.13
Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet (2008) 1.12
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrinol Metab (1988) 1.11
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 4. Assessment of nasolabial appearance. Cleft Palate Craniofac J (1992) 1.10
Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer (2004) 1.09
Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. J Cardiovasc Magn Reson (2006) 1.08
Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene (2011) 1.08
Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol (2007) 1.08
Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium. J Gen Virol (1997) 1.07
Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene (2010) 1.07
Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol Histopathol (2007) 1.07
Two gap junction genes, connexin 31.1 and 30.3, are closely linked on mouse chromosome 4 and preferentially expressed in skin. J Biol Chem (1992) 1.06
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology (2003) 1.06
Total knee replacement in an amputee patient: a case report. Arch Phys Med Rehabil (2000) 1.06
A comparison of subset selection and analysis of covariance for the adjustment of confounders. Psychol Methods (2000) 1.06
Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas. Horm Metab Res (2001) 1.06
Electron microscopic observations on human intracranial arteries. Changes seen with aging and atherosclerosis. Arch Neurol (1967) 1.05
Cardiac function estimation from MRI using a heart model and data assimilation: advances and difficulties. Med Image Anal (2006) 1.05
Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development. Dev Biol (1999) 1.05